statement
The FDA requires a warning about a risk of sudden blindness with popular weight-loss drugs.
A statement by noticias_telemundo. Statements are as reported by the cited publishers — not verified by DecisionGateway.
La FDA exige advertir sobre un riesgo de ceguera repentina con los populares fármacos para adelgazar.
Related claims
The U.S. FDA warned about 마운자로 and 위고비, saying people could lose their eyesight while trying to lose weight.hankyung_fin · allegationWeight-loss drugs may increase the risk of irreversible vision loss.fda · allegationSaudi Arabia warned over possible glass in Arla puddings.gulfnewsuae · statementNovo Nordisk announced that the marketing application for its new drug CagriSema (cagrilintide and semaglutide injection) for long-term weight management has been accepted by the National Medical Products Administration.诺和诺德 · statementA health alert has been issued.ultimahoravzl · statementRegulators are introducing a mandatory waiting period to reduce the risks of ill-considered financial decisions.ekoasia · statement
More claims by noticias_telemundo
The rejection of the new tax on billionaires is a setback for the left.statementVoters in California reject a new tax on billionaires.statementICE arrested an 8-year-old Haitian boy during a routine check, causing an uproar in the San Diego school district.allegationTrump questions the election results after having said he was "absolutamente dispuesto" to accept them.allegationAnother contest for the House of Representatives in Louisiana is going to a runoff.statement
All claims by noticias_telemundo